Senior researchers in the ASPREE (ASPirin in Reducing Events in the Elderly) trial were in Shepparton this week to give the first of several study updates planned for Australian participants this year. Executive Officer of ASPREE, Associate Professor Robyn Woods, presented an update on the aspirin study’s progress at a morning tea for participants living in…
Details
ASPREE Principal Investigator in Australia, Professor John McNeil discussed what the findings of ASPREE may mean to future health care in this week’s GP publication ‘Medical Observer’. He wrote: “Currently, it is not known if low-grade inflammation is a cause or consequence of the diseases of ageing. If ASPREE shows lower incidence of disease and disability among those with reduced inflammatory…
Details
In 2013, the ASPREE (ASPirin in Reducing Events in the Elderly) study reached a number of significant milestones that could not have been reached without the generosity of older Australians, supporting GPs and practice staff and our hard-working team. Congratulations to all. Fun facts about ASPREE in 2013. The trial: • Reached and exceeded the original…
DetailsFantastic to meet so many of our participants and guests at ASPREE study updates in Melbourne, Traralgon, Adelaide and Hobart in 2013. We look forward to seeing you again in 2014.
ASPREE’s biannial participant newsletter is in the post! In this edition, John McNeil thanks our participants for pitching in to help solve big health issues facing older people. We give updates on sub-studies in Australia such as ASPREE – AMD (age-related macular degeneration) and ASPREE-NEURO, to determine whether brain MRIs can accurately predict the risk of stroke…
Details
The ASPREE study does not have preliminary findings at this point in time – the trial is still in the recruitment phase and will continue to be so until mid 2014. If you have further questions, please ring 1800 728 745 (toll free from a landline).
PRESS RELEASE Wollongong locals to participate in Australia’s largest primary prevention Aspirin Trial Wollongong, October 3, 2013 – The ASPREE (ASPirin in Reducing Events in the Elderly) study – the largest primary prevention aspirin study ever undertaken in older people – is calling on local residents from Wollongong and surrounding regions to participate in the study.…
Details
ASPREE has now enrolled over 12,500 participants in Australia, our original target when the trial was launched in 2010. To our wonderful older members of the community participating in ASPREE and to their supportive family and friends and GPs, thank you. Congratulations also to our hardworking team.
Sapphire Coast GP, Dr Mackinnon featured in an article “An aspirin a day for the elderly” in the Bega District News. Dr Mackinnon, one of over 2000 registered co-investigators to ASPREE, the largest clinical trial ever conducted in general practice in Australia, explained why he is involved in this study. Read the full Bega District News…
Details
The ASPREE Healthy Ageing Biobank team marks the 8,000th participant to volunteer for the study with a delightful cake made by one of their talented research assistants.
© 2015 All Rights Reserved. • Monash University, Department of Epidemiology and Preventive Medicine | Disclaimer & Privacy